MXCTvs its industry peers
A metric-by-metric comparison of MXCT against SIC 8731 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MXCTThis | $126M#3 | — | 0.8x#2 | 6.0x#3 | -5.7%#5 | -8.7%#5 | -247.6%#5 | -28.1%#3 | — | — | — | — |
| INCY | $24.6B#1 | 17.4x#1 | 4.4x#3 | 4.8x#2 | 21.2%#3 | 3846.9%#1 | 29.5%#1 | 22.9%#2 | 49.0%#1 | — | — | — |
| MEDP | $17.3B#2 | 36.4x#2 | 39.8x#5 | 6.8x#4 | 20.0%#4 | 11.6%#3 | 21.1%#2 | 104.0%#1 | — | — | 26.1%#1 | — |
| BIAF | $50M#4 | — | 13.3x#4 | 8.2x#5 | -34.2%#6 | -64.9%#6 | -171.6%#4 | -395.6%#4 | -661.2%#3 | — | — | — |
| ONMD | $39M#5 | — | — | 28.8x#6 | 111.4%#2 | 72.3%#2 | -711.3%#6 | — | — | 4#1 | — | — |
| FOXO | $150889#6 | — | 0.2x#1 | 0.0x#1 | 304.0%#1 | -0.2%#4 | -63.1%#3 | -1257.7%#5 | -268.4%#2 | — | — | — |
| BUDZ | — | — | — | — | — | -168.7%#7 | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 8731). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice